MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$3,382,700K
(30.19%↑ Y/Y)
Inventory
$1,949,000K
(-14.29%↓ Y/Y)
Accounts receivable, net
of allowance for...
$1,369,200K
(-14.58%↓ Y/Y)
Other current assets
$1,168,300K
(54.27%↑ Y/Y)
Current portion of
marketable securities
$900,000K
Accounts receivable, net
of allowance for...
$421,200K
(7.01%↑ Y/Y)
Total current assets
$9,190,400K
(20.51%↑ Y/Y)
Intangible assets, net
$9,053,500K
(-5.54%↓ Y/Y)
Goodwill
$6,488,700K
(0.18%↑ Y/Y)
Property, plant and
equipment, net
$3,017,900K
(-3.66%↓ Y/Y)
Investments and other assets
$777,500K
(39.06%↑ Y/Y)
Marketable securities
$465,600K
Operating lease assets
$251,300K
(-27.45%↓ Y/Y)
Deferred tax asset
$238,200K
(-22.54%↓ Y/Y)
Total assets
$29,483,100K
(5.17%↑ Y/Y)
Total liabilities and
equity
$29,483,100K
(5.17%↑ Y/Y)
Total equity
$18,651,700K
(9.85%↑ Y/Y)
Total liabilities
$10,831,400K
(-2.02%↓ Y/Y)
Treasury stock, at cost
$2,977,100K
(0.00%↑ Y/Y)
Accumulated other
comprehensive income (loss)
-$140,200K
(19.66%↑ Y/Y)
Retained earnings
$20,872,200K
(7.04%↑ Y/Y)
Notes payable
$6,288,500K
(38.25%↑ Y/Y)
Total current
liabilities
$2,998,900K
(-43.39%↓ Y/Y)
Other long-term
liabilities
$787,100K
(4.71%↑ Y/Y)
Deferred tax liability
$483,500K
(262.99%↑ Y/Y)
Long-term operating lease
liabilities
$273,400K
(-15.46%↓ Y/Y)
Additional paid-in capital
$896,700K
(42.36%↑ Y/Y)
Common stock, par value
0.0005 per share
$100K
(0.00%↑ Y/Y)
Accrued expense and
other
$2,546,800K
(0.64%↑ Y/Y)
Accounts payable
$358,500K
(-8.43%↓ Y/Y)
Taxes payable
$93,600K
(-85.05%↓ Y/Y)
Back
Back
Balance Sheet
Biogen-svg
source: myfinsight.com
BIOGEN INC. (BIIB)
Biogen-svg
BIOGEN INC. (BIIB)